Global Age-Related Macular Degeneration Market 2016-2020; New Report Launched

DrugPipeline.net has announced the addition of “Global Age-related Macular Degeneration Market 2016-2020” research report to their website DrugPipeline.net


Bangalore, Karnataka -- (SBWIRE) -- 01/06/2017 -- AMD is the degeneration or disintegration of the eye's macula. The macula is a small area of the retina that is responsible for the central vision. AMD can be classified into two types: dry and wet macular degenerations. When the tiny abnormal blood vessels begin growing toward the macula, it develops into wet AMD. Dry AMD occurs when small, yellowish deposits called drusen start accumulating beneath the macula. While some treatments are available for wet AMD; there is no treatment available at the moment for dry AMD.

Report forecast the global age-related macular degeneration (AMD) market to grow at a CAGR of 7.37% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global age-related macular degeneration (AMD) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of AMD.

The market is divided into the following segments based on geography:
- Americas

Global Age-Related Macular Degeneration (AMD) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Bayer HealthCare
- F. Hoffmann-La Roche
- Novartis
- Regeneron Pharmaceuticals

Other prominent vendors
- Alcon
- Allergan
- Adverum Biotechnologies
- Bausch + Lomb
- Gilead Sciences
- Iconic Therapeutics
- Lpath
- Neurotech Pharmaceuticals
- Ohr Pharmaceutical
- Opthea
- Ophthotech
- PanOptica
- Pfizer
- Promedior
- Quark
- Resolvyx Pharmaceuticals
- RXi Pharmaceuticals
- Sagent Pharmaceuticals
- Santen Pharmaceuticals
- Sanwa Kagaku Kenkyusho

Market driver
- Increasing reimbursement benefits for AMD drugs
- For a full, detailed list, view our report

Market challenge
- Availability of alternative therapies
- For a full, detailed list, view our report

Market trend
- Novel treatment approaches for developing AMD drugs
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 99 pages "Global Age-related Macular Degeneration Market 2016-2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Key buying criteria, AMD: Overview, Pipeline portfolio, Market landscape, Market analysis of major drugs, Market segmentation by type, Market segmentation by ROA, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-age-related-macular-degeneration-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.